| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| R&D Expense | $1.4M | -78.1% |
| SG&A Expense | $3.1M | -11.5% |
| Operating Income | -$4.5M | +54.7% |
| Interest Expense | $18K | +78.5% |
| Pre-tax Income | -$4.5M | +54.6% |
| Net Income | -$4.5M | +54.6% |
| EPS (Basic) | -$11.32 | +23.0% |
| EPS (Diluted) | -$11.32 | +23.0% |
| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.9M | +950.0% |
| Current Assets | $4.2M | +817.6% |
| Total Assets | $4.6M | +628.8% |
| Total Liabilities | $635K | -80.3% |
| Stockholders' Equity | $4.0M | +253.0% |
| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.6M | +20.6% |
| Investing Cash Flow | -$300K | -103.7% |
| Financing Cash Flow | $10.4M | +185.9% |